Bob. You've been in since .65. Could you list the accomplishments since you bought in at .65. Or to make it easy. What did CTIX have going at the .65 entry point?
I know when I bought around .50 they did not have one clinical trial. Just pre clinical data for Kevetrin and pre clinical data for Prurisol.
I think it was in the 90's million shares OS? Can't remember though.
Now:125 million OS They own the entire B franchise. Dominated a phase 2b B-Absssi trial that matched Daptomycin which is a billion dollar drug. And B has several huge benefits in comparison. Started a B-OM phase 2 trial for head/neck cancer patients Started a B-Up phase 2 PoC trial that is showing wonderful progress and feedback/results. Signed an agreement having a major Pharm test B on implants and devices to limit infections. That Pharm ordered a second huge batch of B Kevetrin successfully completed a phase 1 trial that took 3 plus years and we never reached an MTD. Very safe unlike any other p53 drug. About to start phase 2 trial w K on ovarian cancer They have tested and continue to develop an ORAL K. All tests look great thus far. Received how many FDA designations? I lost count. Even one that recently was sold for hundreds of millions. At lunch so I can't remember what designation that is called. Prurisol was granted 505(b) and completed a phase 1 cross over study. Completed a PoC phase 2 trial with P showing excellent data at the 200 mg level. Very comparable to Otezla Now started a phase 2b POWERED study at 25 sites.
My finger is tired. But for the amount of what CTIX has been able to accomplish while diluting very little!!!!! I mean I'd expect to see 5-10 dollars a share.
News 
Market Data 
Discover 
